Impact of methamphetamine on infection and immunity

Frontiers in Neuroscience

Volumn 9, Issue JAN, 2015, Pages

  Salamanca, Sergio A ^a   Sorrentino, Edra E ^a   Nosanchuk, Joshua D ^b   Martinez, Luis R ^c  

^a LONG ISLAND UNIVERSITY   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c NEW YORK INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

Drug abuse; HIV; Immunity; Infectious diseases; Methamphetamine; Neurotoxicity

Indexed keywords

METHAMPHETAMINE;

ADAPTIVE IMMUNITY; DISEASE SEVERITY; FUNGUS; HEPATITIS; HIGH RISK PATIENT; HUMAN; IMMUNE RESPONSE; IMMUNITY; INFECTION; INFLAMMATION; INNATE IMMUNITY; METHAMPHETAMINE DEPENDENCE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PREVALENCE; REVIEW; SEXUALLY TRANSMITTED DISEASE; UNITED STATES;

EID: 84921796188     PISSN: 16624548     EISSN: 1662453X     Source Type: Journal    
DOI: 10.3389/fnins.2014.00445     Document Type: Review

References (162)

1. Amantea, D., Russo, R., Gliozzi, M., Fratto, V., Berliocchi, L., Bagetta, G., et al. (2007). Early upregulation of matrix metalloproteinases following reperfusion triggers neuroinflammatory mediators in brain ischemia in rat. Int. Rev. Neurobiol. 82, 149-169. doi: 10.1016/S0074-7742(07)82008-3
2. Anderton, S. M. (2006). Avoiding autoimmune disease-T cells know their limits. Trends Immunol. 27, 208-214. doi: 10.1016/j.it.2006.03.002
3. Barnes, A. J., Smith, M. L., Kacinko, S. L., Schwilke, E. W., Cone, E. J., Moolchan, E. T., et al. (2008). Excretion of methamphetamine and amphetamine in human sweat following controlled oral methamphetamine administration. Clin. Chem. 54, 172-180. doi: 10.1373/clinchem.2007.092304
4. Barry, P. M., Kent, C. K., and Klausner, J. D. (2009). Risk factors for gonorrhea among heterosexuals-San Francisco, 2006. Sex. Transm. Dis. 36, S62-S66. doi: 10.1097/OLQ.0b013e31815faab8
5. Binswanger, I. A., Kral, A. H., Bluthenthal, R. N., Rybold, D. J., and Edlin, B. R. (2000). High prevalence of abscesses and cellulitis among community-recruited injection drug users in San Francisco. Clin. Infect. Dis. 30, 579-581. doi: 10.1086/313703
6. Block, M. L., and Hong, J.-S. (2007). Chronic microglial activation and progressive dopaminergic neurotoxicity. Biochem. Soc. Trans. 35, 1127-1132. doi: 10.1042/BST0351127
7. Borders, T. F., Stewart, K. E., Wright, P. B., Leukefeld, C., Falck, R. S., Carlson, R. G., et al. (2013). Risky sex in rural America: longitudinal changes in a community-based cohort of methamphetamine and cocaine users. Am. J. Addict. 22, 535-542. doi: 10.1111/j.1521-0391.2013.12028.x
8. Bowyer, J. F., Robinson, B., Ali, S., and Schmued, L. C. (2008). Neurotoxic-related changes in tyrosine hydroxylase, microglia, myelin, and the blood-brain barrier in the caudate-putamen from acute methamphetamine exposure. Synapse 62, 193-204. doi: 10.1002/syn.20478
9. Brown, R. E., Group, F. M., Francisco, S., Silverstein, S. J., Morisky, D. E., Determinants, B., et al. (2013). Meth mouth severity in response to drug-use pa tt erns and dental access in methamphetamine users. CDA J. 41, 1-8.
10. Cadet, J. L., and Krasnova, I. N. (2007). Interactions of HIV and methamphetamine: cellular and molecular mechanisms of toxicity potentiation. Neurotox. Res. 12, 181-204. doi: 10.1007/BF03033915
11. Carey, C. L., Woods, S. P., Rippeth, J. D., Gonzalez, R., Heaton, R. K., and Grant, I. (2006). Additive deleterious effects of methamphetamine dependence and immunosuppression on neuropsychological functioning in HIV infection. AIDS Behav. 10, 185-190. doi: 10.1007/s10461-005-9056-4
12. CDC. (2007). Methamphetamine Use and Risk for HIV/AIDS. Atlanta, GA: US Department of Health and Human Services.
13. Cen, P., Ye, L., Su, Q.-J., Wang, X., Li, J.-L., Lin, X.-Q., et al. (2013). Methamphetamine inhibits Toll-like receptor 9-mediated anti-HIV activity in macrophages. AIDS Res. Hum. Retroviruses 29, 1129-1137. doi: 10.1089/AID.2012.0264
14. Chandramani Shivalingappa, P., Jin, H., Anantharam, V., Kanthasamy, A., and Kanthasamy, A. (2012). N-Acetyl cysteine protects against methamphetamine-induced dopaminergic neurodegeneration via modulation of redox status and autophagy in dopaminergic cells. Parkinsons. Dis. 2012, 424285. doi: 10.1155/2012/424285
15. Chaparro-Huerta, V., Rivera-Cervantes, M. C., Flores-Soto, M. E., Gómez-Pinedo, U., and Beas-Zárate, C. (2005). Proinflammatory cytokines and apoptosis following glutamate-induced excitotoxicity mediated by p38 MAPK in the hippocampus of neonatal rats. J. Neuroimmunol. 165, 53-62. doi: 10.1016/j.jneuroim.2005.04.025
16. Chew Ng, R. A., Samuel, M. C., Lo, T., Bernstein, K. T., Aynalem, G., Klausner, J. D., et al. (2013). Sex, drugs (methamphetamines), and the Internet: increasing syphilis among men who have sex with men in California, 2004-2008. Am. J. Public Health 103, 1450-1456. doi: 10.2105/AJPH.2012.300808
17. Cho, A. K., Melega, W. P., Kuczenski, R., and Segal, D. S. (2001). Relevance of pharmacokinetic parameters in animal models of methamphetamine abuse. Synapse 39, 161-166. doi: 10.1002/1098-2396(200102)39:2<161::AID-SYN7>3.0.CO;2-E
18. Chu, J. H., Feudtner, C., Heydon, K., Walsh, T. J., and Zaoutis, T. E. (2006). Hospitalizations for endemic mycoses: a population-based national study. Clin. Infect. Dis. 42, 822-825. doi: 10.1086/500405
19. Cohen, A. L., Shuler, C., McAllister, S., Fosheim, G. E., Brown, M. G., Abercrombie, D., et al. (2007). Methamphetamine use and methicillin-resistant Staphylococcus aureus skin infections. Emerg. Infect. Dis. 13, 1707-1713. doi: 10.3201/eid1311.070148
20. Colfax, G., and Shoptaw, S. (2005). The methamphetamine epidemic: implications for HIV prevention and treatment. Curr. HIV/AIDS Rep. 2, 194-199. doi: 10.1007/s11904-005-0016-4
21. Collins, K. C., Schlosburg, J. E., Lockner, J. W., Bremer, P. T., Ellis, B. A., and Janda, K. D. (2014). Lipid tucaresol as an adjuvant for methamphetamine vaccine development. Chem. Commun. (Camb.) 50, 4079-4081. doi: 10.1039/c4cc00682h
22. Cook, C. E., Jeffcoat, A. R., Sadler, B. M., Hill, J. M., Voyksner, R. D., Pugh, D. E., et al. (1992). Pharmacokinetics of oral methamphetamine and effects of repeated daily dosing in humans. Drug Metab. Dispos. 20, 856-862.
23. Cooper, H. L. F., Brady, J. E., Ciccarone, D., Tempalski, B., Gostnell, K., and Friedman, S. R. (2007). Nationwide increase in the number of hospitalizations for illicit injection drug use-related infective endocarditis. Clin. Infect. Dis. 45, 1200-1203. doi: 10.1086/522176
24. Cranston, R. D., Murphy, R., Weiss, R. E., Da Costa, M., Palefsky, J., Shoptaw, S., et al. (2012). Anal human papillomavirus infection in a street-based sample of drug using HIV-positive men. Int. J. STD AIDS 23, 195-200. doi: 10.1258/ijsa.2011.011169
25. Cruickshank, C. C., and Dyer, K. R. (2009). A review of the clinical pharmacology of methamphetamine. Addiction 104, 1085-1099. doi: 10.1111/j.1360-0443.2009.02564.x
26. Day, C., Ross, J., and Dolan, K. (2003). Hepatitis C-related discrimination among heroin users in Sydney: drug user or hepatitis C discrimination? Drug Alcohol Rev. 22, 317-321. doi: 10.1080/0959523031000154463
27. Downes, M. A., and Whyte, I. M. (2005). Amphetamine-induced movement disorder. Emerg. Med. Australas. 17, 277-280. doi: 10.1111/j.1742-6723.2005.00735.x
28. Drug Enforcement Administration. (2007). New Data Show Significant Disruptions in U.S. Methamphetamine, Cocaine Markets Price of Meth Soars 73 Percent; Purity Down by Nearly a Third. Washington, DC: DEA Public Affairs.
29. Earla, R., Kumar, S., Wang, L., Bosinger, S., Li, J., Shah, A., et al. (2014). Enhanced methamphetamine metabolism in rhesus macaque as compared with human: an analysis using a novel method of liquid chromatography with tandem mass spectrometry, kinetic study, and substrate docking. Drug Metab. Dispos. 42, 2097-2108. doi: 10.1124/dmd.114.059378
30. El-Sharif, A., and Ashour, H. M. (2008). Community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) colonization and infection in intravenous and inhalational opiate drug abusers. Exp. Biol. Med. (Maywood.) 233, 874-880. doi: 10.3181/0711-RM-294
31. Ellis, R. J., Childers, M. E., Cherner, M., Lazzaretto, D., Letendre, S., and Grant, I. (2003). Increased human immunodeficiency virus loads in active methamphetamine users are explained by reduced effectiveness of antiretroviral therapy. J. Infect. Dis. 188, 1820-1826. doi: 10.1086/379894
32. Eugenin, E. A., Greco, J. M., Frases, S., Nosanchuk, J. D., and Martinez, L. R. (2013). Methamphetamine alters blood brain barrier protein expression in mice, facilitating central nervous system infection by neurotropic Cryptococcus neoformans. J. Infect. Dis. 208, 699-704. doi: 10.1093/infdis/jit117
33. Evans, Z. P., Miller, P. M., Sftvmut, Z. F. U., Tjhojgjdbou, T., Gps, U., Boe, M. Q., et al. (2012). Methamphetamine abuse and oral health: a pilot study of "Meth Mouth." Quintessence Int. (Berl.) 43, 229-237.
34. Flora, G., Lee, Y. W., Nath, A., Hennig, B., Maragos, W., and Toborek, M. (2003). Methamphetamine potentiates HIV-1 tat protein-mediated activation of redox-sensitive pathways in discrete regions of the brain. Exp. Neurol. 179, 60-70. doi: 10.1006/exnr.2002.8048
35. Frontera, J. A., and Gradon, J. D. (2000). Right-side endocarditis in injection drug users: review of proposed mechanisms of pathogenesis. Clin. Infect. Dis. 30, 374-379. doi: 10.1086/313664
36. Garfein, R. S., Bower, W. A., Loney, C. M., Hutin, Y. J. F., Xia, G.-L., Jawanda, J., et al. (2004). Factors associated with fulminant liver failure during an outbreak among injection drug users with acute hepatitis B. Hepatology 40, 865-873. doi: 10.1002/hep.20383
37. Garfein, R. S., Metzner, M., Cuevas, J., Bousman, C. A., and Patterson, T. (2010). Formative assessment of ARM-U: a modular intervention for decreasing risk behaviors among HIV-positive and HIV-negative methamphetamine-using MSM. Open AIDS J. 4, 105-115. doi: 10.2174/1874613601004030105
38. Gartner, S., and Liu, Y. (2002). Insights into the role of immune activation in HIV neuropathogenesis. J. Neurovirol. 8, 69-75. doi: 10.1080/13550280290049525
39. Gaskill, P. J., Calderon, T. M., Luers, A. J., Eugenin, E. A., Javitch, J. A., and Berman, J. W. (2009). Human immunodeficiency virus (HIV) infection of human macrophages is increased by dopamine: a bridge between HIV-associated neurologic disorders and drug abuse. Am. J. Pathol. 175, 1148-1159. doi: 10.2353/ajpath.2009.081067
40. Gong, W., Ritter, A., Bright, D., and Doran, C. (2012). How profitable is methamphetamine dealing in Australia? Drug Alcohol Depend. 122, 208-212. doi: 10.1016/j.drugalcdep.2011.09.028
41. Gonzales, R., Marinelli-Casey, P., Hillhouse, M., Hunter, J., Rawson, R. A., Mooney, L., et al. (2008). Hepatitis A and B infection among methamphetamine-dependent users. J. Subst. Abuse Treat. 35, 351-352. doi: 10.1016/j.jsat.2008.05.001
42. Gonzales, R., Marinelli-Casey, P., Shoptaw, S., Ang, A., and Rawson, R. A. (2006). Hepatitis C virus infection among methamphetamine-dependent individuals in outpatient treatment. J. Subst. Abuse Treat. 31, 195-202. doi: 10.1016/j.jsat.2006.04.006
43. Goodchild, J. H., and Donaldson, M. (2007). Methamphetamine abuse and dentistry: a review of the literature and presentation of a clinical case. Quintessence Int. 38, 583-590.
44. Gordon, R. J., and Lowy, F. D. (2005). Bacterial infections in drug users. N. Engl. J. Med. 353, 1945-1954. doi: 10.1056/NEJMra042823
45. Hagan, H., Thiede, H., and Des Jarlais, D. C. (2005). HIV/hepatitis C virus co-infection in drug users: risk behavior and prevention. AIDS 19 (Suppl. 3), S199-S207. doi: 10.1097/01.aids.0000192090.61753.d4
46. Hahn, J. A., Page-Shafer, K., Lum, P. J., Ochoa, K., and Moss, A. R. (2001). Hepatitis C virus infection and needle exchange use among young injection drug users in San Francisco. Hepatology 34, 180-187. doi: 10.1053/jhep.2001.25759
47. Hamamoto, D. T., and Rhodus, N. L. (2009). Methamphetamine abuse and dentistry. Oral Dis. 15, 27-37. doi: 10.1111/j.1601-0825.2008.01459.x
48. Hambuchen, M. D., Rüedi-Bettschen, D., Williams, D. K., Hendrickson, H., and Owens, S. M. (2014). Treatment of rats with an anti-(+)-methamphetamine monoclonal antibody shortens the duration of action of repeated (+)-methamphetamine challenges over a one month period. Vaccine 32, 6213-6219. doi: 10.1016/j.vaccine.2014.09.025
49. Haorah, J., Ramirez, S. H., Schall, K., Smith, D., Pandya, R., and Persidsky, Y. (2007). Oxidative stress activates protein tyrosine kinase and matrix metalloproteinases leading to blood-brain barrier dysfunction. J. Neurochem. 101, 566-576. doi: 10.1111/j.1471-4159.2006.04393.x
50. Harms, R., Morsey, B., Boyer, C. W., Fox, H. S., and Sarvetnick, N. (2012). Methamphetamine administration targets multiple immune subsets and induces phenotypic alterations suggestive of immunosuppression. PLoS ONE 7:e49897. doi: 10.1371/journal.pone.0049897
51. Harris, D. S., Boxenbaum, H., Everhart, E. T., Sequeira, G., Mendelson, J. E., and Jones, R. T. (2003). The bioavailability of intranasal and smoked methamphetamine. Clin. Pharmacol. Ther. 74, 475-486. doi: 10.1016/j.clpt.2003.08.002
52. Hart, C. L., Gunderson, E. W., Perez, A., Kirkpatrick, M. G., Thurmond, A., Comer, S. D., et al. (2008). Acute physiological and behavioral effects of intranasal methamphetamine in humans. Neuropsychopharmacology 33, 1847-1855. doi: 10.1038/sj.npp.1301578
53. Hendrickson, H. P., Hardwick, W. C., McMillan, D. E., and Owens, S. M. (2008). Bioavailability of (+)-methamphetamine in the pigeon following an intramuscular dose. Pharmacol. Biochem. Behav. 90, 382-386. doi: 10.1016/j.pbb.2008.03.012
54. Heng, C. K., Badner, V. M., and Schiop, L. A. (2008). Meth mouth. N.Y. State Dent. J. 74, 50-51.
55. Heninger, M., and Collins, K., a (2013). Acute bacterial meningitis with coincident methamphetamine use: a case report and review of the literature. J. Forensic Sci. 58, 1088-1091. doi: 10.1111/1556-4029.12176
56. Hirshfield, S., Remien, R. H., Humberstone, M., Walavalkar, I., and Chiasson, M. (2004a). Substance use and high-risk sex among men who have sex with men: a national online study in the USA. AIDS Care 16, 1036-1047. doi: 10.1080/09540120412331292525
57. Hirshfield, S., Remien, R. H., Walavalkar, I., and Chiasson, M. A. (2004b). Crystal methamphetamine use predicts incident STD infection among men who have sex with men recruited online: a nested case-control study. J. Med. Internet Res. 6:e41. doi: 10.2196/jmir.6.4.e41
58. In, S.-W., Son, E.-W., Rhee, D.-K., and Pyo, S. (2005). Methamphetamine administration produces immunomodulation in mice. J. Toxicol. Environ. Health. A 68, 2133-2145. doi: 10.1080/15287390500177156
59. Ito, H., Kanno, I., Ibaraki, M., Hatazawa, J., and Miura, S. (2003). Changes in human cerebral blood flow and cerebral blood volume during hypercapnia and hypocapnia measured by positron emission tomography. J. Cereb. Blood Flow Metab. 23, 665-670. doi: 10.1097/01.WCB.0000067721.64998.F5
60. Ito, K., Abekawa, T., and Koyama, T. (2006). Relationship between development of cross-sensitization to MK-801 and delayed increases in glutamate levels in the nucleus accumbens induced by a high dose of methamphetamine. Psychopharmacology (Berl.) 187, 293-302. doi: 10.1007/s00213-006-0423-2
61. Jackson, A. R., Shah, A., and Kumar, A. (2014). Methamphetamine alters the normal progression by inducing cell cycle arrest in astrocytes. PLoS ONE 9:e109603. doi: 10.1371/journal.pone.0109603
62. Javanbakht, M., Gorbach, P., Stirland, A., Chien, M., Kerndt, P., and Guerry, S. (2012). Prevalence and correlates of rectal Chlamydia and gonorrhea among female clients at sexually transmitted disease clinics. Sex. Transm. Dis. 39, 917-922. doi: 10.1097/OLQ.0b013e31826ae9a2
63. Johnston, C. L., Callon, C., Li, K., Wood, E., and Kerr, T. (2010). Offer of financial incentives for unprotected sex in the context of sex work. Drug Alcohol Rev. 29, 144-149. doi: 10.1111/j.1465-3362.2009.00091.x
64. Kang, D., Liao, M., Jiang, Z., Zhang, X., Mao, W., Zhang, N., et al. (2011). Commercial sex venues, syphilis and methamphetamine use among female sex workers. AIDS Care 23 (Suppl. 1), 26-36. doi: 10.1080/09540121.2011.560930
65. Kaye, S., Darke, S., Duflou, J., and McKetin, R. (2008). Methamphetamine-related fatalities in Australia: demographics, circumstances, toxicology and major organ pathology. Addiction 103, 1353-1360. doi: 10.1111/j.1360-0443.2008.02231.x
66. Khan, M. R., Berger, A., Hemberg, J., O'Neill, A., Dyer, T. P., and Smyrk, K. (2013). Non-injection and injection drug use and STI/HIV risk in the United States: the degree to which sexual risk behaviors versus sex with an STI-infected partner account for infection transmission among drug users. AIDS Behav. 17, 1185-1194. doi: 10.1007/s10461-012-0276-0
67. Kim, Y. S., Kim, S. S., Cho, J. J., Choi, D. H., Hwang, O., Shin, D. H., et al. (2005). Matrix metalloproteinase-3: a novel signaling proteinase from apoptotic neuronal cells that activates microglia. J. Neurosci. 25, 3701-3711. doi: 10.1523/JNEUROSCI.4346-04.2005
68. Klevens, R. M., Miller, J., Vonderwahl, C., Speers, S., Alelis, K., Sweet, K., et al. (2009). Population-based surveillance for hepatitis C virus, United States, 2006-2007. Emerg. Infect. Dis. 15, 1499-1502. doi: 10.3201/eid1509.081050
69. Kousik, S. M., Napier, T. C., Ross, R. D., Sumner, D. R., and Carvey, P. M. (2014). Dopamine receptors and the persistent neurovascular dysregulation induced by methamphetamine self-administration in rats. J. Pharmacol. Exp. Ther. 351, 432-439. doi: 10.1124/jpet.114.217802
70. Krasnova, I. N., Justinova, Z., Ladenheim, B., Jayanthi, S., McCoy, M. T., Barnes, C., et al. (2010). Methamphetamine self-administration is associated with persistent biochemical alterations in striatal and cortical dopaminergic terminals in the rat. PLoS ONE 5:e8790. doi: 10.1371/journal.pone.0008790
71. Kuczenski, R., Segal, D. S., Melega, W. P., Lacan, G., and McCunney, S. J. (2009). Human methamphetamine pharmacokinetics simulated in the rat: behavioral and neurochemical effects of a 72-h binge. Neuropsychopharmacology 34, 2430-2441. doi: 10.1038/npp.2009.73
72. Kutyshenko, V. P., Molchanov, M., Beskaravayny, P., Uversky, V. N., and Timchenko, M., a (2011). Analyzing and mapping sweat metabolomics by high-resolution NMR spectroscopy. PLoS ONE 6:e28824. doi: 10.1371/journal.pone.0028824
73. Lea, T., Mao, L., Bath, N., Prestage, G., Zablotska, I., de Wit, J., et al. (2013). Injecting drug use among gay and bisexual men in Sydney: prevalence and associations with sexual risk practices and HIV and hepatitis C infection. AIDS Behav. 17, 1344-1351. doi: 10.1007/s10461-013-0409-0
74. Letendre, S. L., Cherner, M., Ellis, R. J., Marquie-Beck, J., Gragg, B., Marcotte, T., et al. (2005). The effects of hepatitis C, HIV, and methamphetamine dependence on neuropsychological performance: biological correlates of disease. AIDS 19 (Suppl. 3), S72-S78. doi: 10.1097/01.aids.0000192073.18691.ff
75. Letendre, S., Paulino, A. D., Rockenstein, E., Adame, A., Crews, L., Cherner, M., et al. (2007). Pathogenesis of hepatitis C virus coinfection in the brains of patients infected with HIV. J. Infect. Dis. 196, 361-370. doi: 10.1086/519285
76. Li, L., Everhart, T., Jacob III, P., Jones, R., and Mendelson, J. (2010). Stereoselectivity in the human metabolism of methamphetamine. Br. J. Clin. Pharmacol. 69, 187-192. doi: 10.1111/j.1365-2125.2009.03576.x
77. Liang, H., Wang, X., Chen, H., Song, L., Ye, L., Wang, S.-H., et al. (2008). Methamphetamine enhances HIV infection of macrophages. Am. J. Pathol. 172, 1617-1624. doi: 10.2353/ajpath.2008.070971
78. Liao, M., Kang, D., Tao, X., Cox, C., Qian, Y., Wang, G., et al. (2014). Syndemics of syphilis, HCV infection, and methamphetamine use along the east coast of China. BMC Public Health 14:172. doi: 10.1186/1471-2458-14-172
79. Liao, M., Kang, D., Tao, X., Li, J., Qian, Y., Wang, G., et al. (2013). Dual epidemics of syphilis and methamphetamine use among drug users in Shandong Province of China. AIDS Care 25, 1236-1244. doi: 10.1080/09540121.2013.764384
80. Liu, X., Silverstein, P. S., Singh, V., Shah, A., Qureshi, N., and Kumar, A. (2012). Methamphetamine increases LPS-mediated expression of IL-8, TNF-a and IL-1ß in human macrophages through common signaling pathways. PLoS ONE 7:e33822. doi: 10.1371/journal.pone.0033822
81. Loftis, J. M., Choi, D., Hoffman, W., and Huckans, M. S. (2011). Methamphetamine causes persistent immune dysregulation: a cross-species, translational report. Neurotox. Res. 20, 59-68. doi: 10.1007/s12640-010-9223-x
82. Mahajan, S. D., Aalinkeel, R., Sykes, D. E., Reynolds, J. L., Bindukumar, B., Adal, A., et al. (2008). Methamphetamine alters blood brain barrier permeability via the modulation of tight junction expression: implication for HIV-1 neuropathogenesis in the context of drug abuse. Brain Res. 1203, 133-148. doi: 10.1016/j.brainres.2008.01.093
83. Mahajan, S. D., Hu, Z., Reynolds, J. L., Aalinkeel, R., Schwartz, S. A., and Nair, M. P. N. (2006). Methamphetamine modulates gene expression patterns in monocyte derived mature dendritic cells: implications for HIV-1 pathogenesis. Mol. Diagn. Ther. 10, 257-269. doi: 10.1007/BF03256465
84. Mansergh, G., Purcell, D. W., Stall, R., McFarlane, M., Semaan, S., Valentine, J., et al. (2006). CDC consultation on methamphetamine use and sexual risk behavior for HIV/STD infection: summary and suggestions. Public Health Rep. 121, 127-132.
85. Marcondes, M. C. G., Flynn, C., Watry, D. D., Zandonatti, M., and Fox, H. S. (2010). Methamphetamine increases brain viral load and activates natural killer cells in simian immunodeficiency virus-infected monkeys. Am. J. Pathol. 177, 355-361. doi: 10.2353/ajpath.2010.090953
86. Marshall, B. D. L., Wood, E., Shoveller, J. A., Patterson, T. L., Montaner, J. S. G., and Kerr, T. (2011). Pathways to HIV risk and vulnerability among lesbian, gay, bisexual, and transgendered methamphetamine users: a multi-cohort gender-based analysis. BMC Public Health 11:20. doi: 10.1186/1471-2458-11-20
87. Martinez, L. R., Mihu, M. R., Gácser, A., Santambrogio, L., and Nosanchuk, J. D. (2009). Methamphetamine enhances histoplasmosis by immunosuppression of the host. J. Infect. Dis. 200, 131-141. doi: 10.1086/599328
88. Martins, T., Baptista, S., Gonçalves, J., Leal, E., Milhazes, N., Borges, F., et al. (2011). Methamphetamine transiently increases the blood-brain barrier permeability in the hippocampus: role of tight junction proteins and matrix metalloproteinase-9. Brain Res. 1411, 28-40. doi: 10.1016/j.brainres.2011.07.013
89. Martins, T., Burgoyne, T., Kenny, B.-A., Hudson, N., Futter, C. E., Ambrósio, A. F., et al. (2013). Methamphetamine-induced nitric oxide promotes vesicular transport in blood-brain barrier endothelial cells. Neuropharmacology 65, 74-82. doi: 10.1016/j.neuropharm.2012.08.021
90. Marwick, C. (2000). NIDA seeking data on effect of fetal exposure to methamphetamine. JAMA 283, 2225-2226. doi: 10.1001/jama.283.17.2225-JMN0503-2-1
91. McColl, B. W., Rothwell, N. J., and Allan, S. M. (2008). Systemic inflammation alters the kinetics of cerebrovascular tight junction disruption after experimental stroke in mice. J. Neurosci. 28, 9451-9462. doi: 10.1523/JNEUROSCI.2674-08.2008
92. Melega, W. P., Cho, A. K., Harvey, D., and Laæan, G. (2007). Methamphetamine blood concentrations in human abusers: application to pharmacokinetic modeling. Synapse 61, 216-220. doi: 10.1002/syn.20365
93. Miller, C. L., Kerr, T., Fischer, B., Zhang, R., and Wood, E. (2009). Methamphetamine injection independently predicts hepatitis C infection among street-involved youth in a Canadian setting. J. Adolesc. Health 44, 302-304. doi: 10.1016/j.jadohealth.2008.08.007
94. Miller, C. L., Wood, E., Spittal, P. M., Li, K., Frankish, J. C., Braitstein, P., et al. (2004). The future face of coinfection. JAIDS J. Acquir. Immune Defic. Syndr. 36, 743-749. doi: 10.1097/00126334-200406010-00012
95. Miller, K. S., Maxwell, K. D., Fasula, A. M., Parker, J. T., Zackery, S., and Wyckoff, S. C. (2010). Pre-risk HIV-prevention paradigm shift: the feasibility and acceptability of the parents matter! Program in HIV risk communities. Public Health Rep. 125 (Suppl.), 38-46.
96. Mimiaga, M. J., Reisner, S. L., Vanderwarker, R., Gaucher, M. J., O'Connor, C., a Medeiros, M. S., et al. (2008). Polysubstance use and HIV/STD risk behavior among Massachusetts men who have sex with men accessing Department of Public Health mobile van services: implications for intervention development. AIDS Patient Care STDS 22, 745-751. doi: 10.1089/apc.2007.0243
97. Miyatake, M., Narita, M., Shibasaki, M., Nakamura, A., and Suzuki, T. (2005). Glutamatergic neurotransmission and protein kinase C play a role in neuron-glia communication during the development of methamphetamine-induced psychological dependence. Eur. J. Neurosci. 22, 1476-1488. doi: 10.1111/j.1460-9568.2005.04325.x
98. Naar-King, S., Parsons, J. T., Murphy, D., Kolmodin, K., and Harris, D. R. (2010). A multisite randomized trial of a motivational intervention targeting multiple risks in youth living with HIV: initial effects on motivation, self-efficacy, and depression. J. Adolesc. Health 46, 422-428. doi: 10.1016/j.jadohealth.2009.11.198
99. Nair, M. P. N., and Saiyed, Z. M. (2011). Effect of methamphetamine on expression of HIV coreceptors and CC-chemokines by dendritic cells. Life Sci. 88, 987-994. doi: 10.1016/j.lfs.2010.09.019
100. Nair, M. P. N., Saiyed, Z. M., Nair, N., Gandhi, N. H., Rodriguez, J. W., Boukli, N., et al. (2009). Methamphetamine enhances HIV-1 infectivity in monocyte derived dendritic cells. J. Neuroimmune Pharmacol. 4, 129-139. doi: 10.1007/s11481-008-9128-0
101. Nair, M. P. N., and Samikkannu, T. (2012). Differential regulation of neurotoxin in HIV clades: role of cocaine and methamphetamine. Curr. HIV Res. 10, 429-34. doi: 10.2174/157016212802138742
102. Nakamura, N., Semple, S. J., Strathdee, S. A., and Patterson, T. L. (2011). HIV risk profiles among HIV-positive, methamphetamine-using men who have sex with both men and women. Arch. Sex. Behav. 40, 793-801. doi: 10.1007/s10508-010-9713-1
103. Neumann, H. (2001). Control of glial immune function by neurons. Glia 36, 191-199. doi: 10.1002/glia.1108
104. Northrop, N. A., and Yamamoto, B. K. (2012). Persistent neuroinflamatory effects of serial exposure to stress and methamphetamine on the blood-brain barrier. J. Neuroimmune Pharmacol. 7, 951-968. doi: 10.1007/s11481-012-9391-y. Persistent
105. Panenka, W. J., Procyshyn, R. M., Lecomte, T., MacEwan, G. W., Flynn, S. W., Honer, W. G., et al. (2013). Methamphetamine use: a comprehensive review of molecular, preclinical and clinical findings. Drug Alcohol Depend. 129, 167-179. doi: 10.1016/j.drugalcdep.2012.11.016
106. Park, B. J., Wannemuehler, K. A., Marston, B. J., Govender, N., Pappas, P. G., and Chiller, T. M. (2009). Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS. AIDS 23, 525-530. doi: 10.1097/QAD.0b013e328322ffac
107. Park, M., Kim, H.-J., Lim, B., Wylegala, A., and Toborek, M. (2013). Methamphetamine-induced occludin endocytosis is mediated by the Arp2/3 complex-regulated actin rearrangement. J. Biol. Chem. 288, 33324-33334. doi: 10.1074/jbc. M113.483487
108. Parry, C. D. H., Plüddemann, A., Myers, B., Wechsberg, W. M., and Flisher, A. J. (2011). Methamphetamine use and sexual risk behaviour in Cape Town, South Africa: a review of data from 8 studies conducted between 2004 and 2007. Afr. J. Psychiatry 14, 372-376. doi: 10.4314/ajpsy.v14i5.4
109. Patel, D., Desai, G. M., Frases, S., Cordero, R. J. B., DeLeon-Rodriguez, C. M., Eugenin, E. A., et al. (2013). Methamphetamine enhances Cryptococcus neoformans pulmonary infection and dissemination to the brain. MBio 4:e00400-13. doi: 10.1128/mBio.00400-13
110. Peerzada, H., Gandhi, J. A., Guimaraes, A. J., Nosanchuk, J. D., and Martinez, L. R. (2013). Methamphetamine administration modifies leukocyte proliferation and cytokine production in murine tissues. Immunobiology 218, 1063-1068. doi: 10.1016/j.imbio.2013.02.001
111. Peterson, E. C., Celikel, R., Gokulan, K., and Varughese, K. I. (2013). Structural characterization of a therapeutic anti-methamphetamine antibody fragment: oligomerization and binding of active metabolites. PLoS ONE 8:e82690. doi: 10.1371/journal.pone.0082690
112. Plankey, M. W., Ostrow, D. G., Stall, R., Cox, C., Li, X., Peck, J., et al. (2007). The relationship between methamphetamine and popper use and risk of HIV seroconversion in the multicenter AIDS cohort study. J. Acquir. Immune Defic. Syndr. 45, 85-92. doi: 10.1097/QAI.0b013e3180417c99
113. Potula, R., Hawkins, B. J., Cenna, J. M., Fan, S., Dykstra, H., Ramirez, S. H., et al. (2010). Methamphetamine causes mitrochondrial oxidative damage in human T lymphocytes leading to functional impairment. J. Immunol. 185, 2867-2876. doi: 10.4049/jimmunol.0903691
114. Proksch, E., Brandner, J. M., and Jensen, J.-M. (2008). The skin: an indispensable barrier. Exp. Dermatol. 17, 1063-1072. doi: 10.1111/j.1600-0625.2008.00786.x
115. Ramirez, S. H., Potula, R., Fan, S., Eidem, T., Papugani, A., Reichenbach, N., et al. (2009). Methamphetamine disrupts blood-brain barrier function by induction of oxidative stress in brain endothelial cells. J. Cereb Blood Flow Metab. 29, 1933-1945. doi: 10.1038/jcbfm.2009.112
116. Ranger, S., Aussel, L., Weinbreck, P., Loustaud, V., Rogues, A. M., Mounier, M., et al. (1991). [Seroprevalence of hepatitis C in human immunodeficiency virus infected patients]. Pathol. Biol. (Paris.) 39, 126-30.
117. Rawson, R. A., Marinelli-Casey, P., Anglin, M. D., Dickow, A., Frazier, Y., Gallagher, C., et al. (2004). A multi-site comparison of psychosocial approaches for the treatment of methamphetamine dependence. Addiction 99, 708-717. doi: 10.1111/j.1360-0443.2004.00707.x
118. Reynolds, J. L., Mahajan, S. D., Sykes, D. E., Schwartz, S. A., and Nair, M. P. N. (2007). Proteomic analyses of methamphetamine (METH)-induced differential protein expression by immature dendritic cells (IDC). Biochim. Biophys. Acta 1774, 433-442. doi: 10.1016/j.bbapap.2007.02.001
119. Rhodes, S. D., Hergenrather, K. C., Yee, L. J., Knipper, E., Wilkin, A. M., and Omli, M. R. (2007). Characteristics of a sample of men who have sex with men, recruited from gay bars and Internet chat rooms, who report methamphetamine use. AIDS Patient Care STDS 21, 575-583. doi: 10.1089/apc.2007.0002
120. Richards, J. R., and Brofeldt, B. T. (2000). Patterns of tooth wear associated with methamphetamine use. J. Periodontol. 71, 1371-1374. doi: 10.1902/jop.2000.71.8.1371
121. Rieg, S., Seeber, S., Steffen, H., Humeny, A., Kalbacher, H., Stevanovic, S., et al. (2006). Generation of multiple stable dermcidin-derived antimicrobial peptides in sweat of different body sites. J. Invest. Dermatol. 126, 354-365. doi: 10.1038/sj.jid.5700041
122. Rippeth, J. D., Heaton, R. K., Carey, C. L., Marcotte, T. D., Moore, D. J., Gonzalez, R., et al. (2004). Methamphetamine dependence increases risk of neuropsychological impairment in HIV infected persons. J. Int. Neuropsychol. Soc. 10, 1-14. doi: 10.1017/S1355617704101021
123. Rivière, G. J., Gentry, W. B., and Owens, S. M. (2000). Disposition of methamphetamine and its metabolite amphetamine in brain and other tissues in rats after intravenous administration. J. Pharmacol. Exp. Ther. 292, 1042-1047.
124. Roberts, A. J., Maung, R., Sejbuk, N. E., Ake, C., and Kaul, M. (2010). Alteration of Methamphetamine-induced stereotypic behaviour in transgenic mice expressing HIV-1 envelope protein gp120. J. Neurosci. Methods 186, 222-225. doi: 10.1016/j.jneumeth.2009.11.007
125. Roll, J. M., Petry, N. M., Stitzer, M. L., Brecht, M. L., Peirce, J. M., McCann, M. J., et al. (2006). Contingency management for the treatment of methamphetamine use disorders. Am. J. Psychiatry 163, 1993-1999. doi: 10.1176/appi.ajp.163.11.1993
126. Rüedi-Bettschen, D., Wood, S. L., Gunnell, M. G., West, C. M., Pidaparthi, R. R., Carroll, F. I., et al. (2013). Vaccination protects rats from methamphetamine-induced impairment of behavioral responding for food. Vaccine 31, 4596-4602. doi: 10.1016/j.vaccine.2013.07.038
127. Rusyniak, D. E. (2013). Neurologic manifestations of chronic methamphetamine abuse. Psychiatr. Clin. North Am. 36, 261-275. doi: 10.1016/j.psc.2013.02.005
128. Saini, T., Edwards, P. C., Kimmes, N. S., Carroll, L. R., Shaner, J. W., and Dowd, F. J. (2005). Etiology of xerostomia and dental caries among methamphetamine abusers. Oral Health Prev. Dent. 3, 189-195. doi: 10.3290/j.ohpd.a10643
129. Saito, M., Terada, M., Kawata, T., Ito, H., Shigematsu, N., Kromkhun, P., et al. (2008). Effects of single or repeated administrations of methamphetamine on immune response in mice. Exp. Anim. 57, 35-43. doi: 10.1538/expanim.57.35
130. Saito, M., Yamaguchi, T., Kawata, T., and Ito, H. (2006). Effects of methamphetamine on cortisone concentration, nk cell activity and mitogen response of t-lymphocytes in female cynomolgus monkeys. Exp. Anim 55, 477-481. doi: 10.1538/expanim.55.477
131. Semple, S. J., Zians, J., Strathdee, S. A., and Patterson, T. L. (2008). Methamphetamine-using felons: psychosocial and behavioral characteristics. Am. J. Addict. 17, 28-35. doi: 10.1080/10550490701756294
132. Shah, A., Silverstein, P. S., Singh, D. P., and Kumar, A. (2012). Involvement of metabotropic glutamate receptor 5, AKT/PI3K signaling and NF-?B pathway in methamphetamine-mediated increase in IL-6 and IL-8 expression in astrocytes. J. Neuroinflammation 9, 52. doi: 10.1186/1742-2094-9-52
133. Shaner, J. W., Kimmes, N., Saini, T., and Edwards, P. (2006). "Meth mouth": rampant caries in methamphetamine abusers. AIDS Patient Care STDS 20, 146-150. doi: 10.1089/apc.2006.20.146
134. Sharma, A., Hu, X.-T., Napier, T. C., and Al-Harthi, L. (2011). Methamphetamine and HIV-1 Tat down regulate ß-catenin signaling: implications for methampetamine abuse and HIV-1 co-morbidity. J. Neuroimmune Pharmacol. 6, 597-607. doi: 10.1007/s11481-011-9295-2
135. Sharma, H. S., and Kiyatkin, E. A. (2009). Rapid morphological brain abnormalities during acute methamphetamine intoxication in the rat: an experimental study using light and electron microscopy. J. Chem. Neuroanat. 37, 18-32. doi: 10.1016/j.jchemneu.2008.08.002
136. Sharma, H. S., Sjöquist, P.-O., and Ali, S. F. (2007). Drugs of abuse-induced hyperthermia, blood-brain barrier dysfunction and neurotoxicity: neuroprotective effects of a new antioxidant compound H-290/51. Curr. Pharm. Des. 13, 1903-1923. doi: 10.2174/138161207780858375
137. Shoptaw, S., Reback, C. J., and Freese, T. E. (2002). Patient characteristics, HIV serostatus, and risk behaviors among gay and bisexual males seeking treatment for methamphetamine abuse and dependence in Los Angeles. J. Addict. Dis. 21, 91-105. doi: 10.1300/J069v21n01
138. Smyth, B. P., Barry, J., and Keenan, E. (2005). Irish injecting drug users and hepatitis C: the importance of the social context of injecting. Int. J. Epidemiol. 34, 166-172. doi: 10.1093/ije/dyh347
139. Soriano, V., Sulkowski, M., Bergin, C., Hatzakis, A., Cacoub, P., Katlama, C., et al. (2002). Care of patients with chronic hepatitis C and HIV co-infection: recommendations from the HIV-HCV International Panel. AIDS 16, 813-828. doi: 10.1097/00002030-200204120-00001
140. Stahlman, S., Javanbakht, M., Stirland, A., Guerry, S., and Gorbach, P. M. (2013). Methamphetamine use among women attending sexually transmitted disease clinics in Los Angeles County. Sex. Transm. Dis. 40, 632-638. doi: 10.1097/01.OLQ.0000430801.14841.75
141. Sutcliffe, C. G., Aramrattana, A., Sherman, S. G., Sirirojn, B., German, D., Wongworapat, K., et al. (2009). Incidence of HIV and sexually transmitted infections and risk factors for acquisition among young methamphetamine users in northern Thailand. Sex. Transm. Dis. 36, 284-289. doi: 10.1097/OLQ.0b013e318191ba17
142. Tallóczy, Z., Martinez, J., Joset, D., Ray, Y., Gácser, A., Toussi, S., et al. (2008). Methamphetamine inhibits antigen processing, presentation, and phagocytosis. PLoS Pathog. 4:e28. doi: 10.1371/journal.ppat.0040028
143. Taylor, M. M., Aynalem, G., Smith, L. V., Montoya, J., and Kerndt, P. (2007). Methamphetamine use and sexual risk behaviours among men who have sex with men diagnosed with early syphilis in Los Angeles County. Int. J. STD AIDS 18, 93-97. doi: 10.1258/095646207779949709
144. Thomas, D. M., and Kuhn, D. M. (2005). MK-801 and dextromethorphan block microglial activation and protect against methamphetamine-induced neurotoxicity. Brain Res. 1050, 190-198. doi: 10.1016/j.brainres.2005.05.049
145. Toussi, S. S., Joseph, A., Zheng, J. H., Dutta, M., Santambrogio, L., and Goldstein, H. (2009). Short communication: Methamphetamine treatment increases in vitro and in vivo HIV replication. AIDS Res. Hum. Retroviruses 25, 1117-1121. doi: 10.1089/aid.2008.0282
146. United Nations. (2011). Amphetamines and Ecstasy: 2011 Global ATS Assessment. Vienna: United Nations Office on Drugs and Crime.
147. Urbina, J. A., Concepcion, J. L., Caldera, A., Payares, G., Sanoja, C., Otomo, T., et al. (2004). In vitro and in vivo activities of E5700 and ER-119884, two novel orally active squalene synthase inhibitors, against Trypanosoma cruzi. Antimicrob. Agents Chemother. 48, 2379-2387. doi: 10.1128/AAC.48.7.2379-2387.2004
148. Urrutia, A., Rubio-Araiz, A., Gutierrez-Lopez, M. D., ElAli, A., Hermann, D. M., O'Shea, E., et al. (2013). A study on the effect of JNK inhibitor, SP600125, on the disruption of blood-brain barrier induced by methamphetamine. Neurobiol. Dis. 50, 49-58. doi: 10.1016/j.nbd.2012.10.006
149. Valencia, F., Bubar, M. J., Milligan, G., Cunningham, K. A., and Bourne, N. (2012). Influence of methamphetamine on genital herpes simplex virus type 2 infection in a mouse model. Sex. Transm. Dis. 39, 720-7255. doi: 10.1097/OLQ.0b013e31825af129
150. Vogt, T. M., Perz, J. F., Van Houten, C. K., Harrington, R., Hansuld, T., Bialek, S. R., et al. (2006). An outbreak of hepatitis B virus infection among methamphetamine injectors: the role of sharing injection drug equipment. Addiction 101, 726-730. doi: 10.1111/j.1360-0443.2006.01407.x
151. Volkow, N. D., Fowler, J. S., Wang, G.-J., Shumay, E., Telang, F., Thanos, P. K., et al. (2010). Distribution and pharmacokinetics of methamphetamine in the human body: clinical implications. PLoS ONE 5:e15269. doi: 10.1371/journal.pone.0015269
152. Volkow, N. D., Wang, G.-J., Fowler, J. S., Telang, F., Jayne, M., and Wong, C. (2007). Stimulant-induced enhanced sexual desire as a potential contributing factor in HIV transmission. Am. J. Psychiatry 164, 157-160. doi: 10.1176/appi.ajp.164.1.157
153. Wang, X., Wang, Y., Ye, L., Li, J., Zhou, Y., Sakarcan, S., et al. (2012). Modulation of intracellular restriction factors contributes to methamphetamine-mediated enhancement of acquired immune deficiency syndrome virus infection of macrophages. Curr. HIV Res. 10, 407-414. doi: 10.2174/157016212802138797
154. Wijetunga, M., Seto, T., Lindsay, J., and Schatz, I. (2003). Crystal methamphetamine-associated cardiomyopathy: tip of the iceberg? J. Toxicol. Clin. Toxicol. 41, 981-986. doi: 10.1081/CLT-120026521
155. Williams, K. C., and Hickey, W. F. (2002). Central nervous system damage, monocytes and macrophages, and neurological disorders in AIDS. Annu. Rev. Neurosci. 25, 537-562. doi: 10.1146/annurev.neuro.25.112701.142822
156. Wong, W., Chaw, J. K., Kent, C. K., and Klausner, J. D. (2005). Risk Factors for Early Syphilis Among Gay and Bisexual Men Seen in an STD Clinic: San Francisco, 2002???2003. Sex. Transm. Dis. 32, 458-463. doi: 10.1097/01.olq.0000168280.34424.58
157. Xiao, Y., Sun, J., Li, C., Lu, F., Allen, K. L., Vermund, S. H., et al. (2010). Prevalence and correlates of HIV and syphilis infections among men who have sex with men in seven provinces in China with historically low HIV prevalence. J. Acquir. Immune Defic. Syndr. 53 (Suppl. 1), S66-S73. doi: 10.1097/QAI.0b013e3181c7db43
158. Yamamoto, B. K., Moszczynska, A., and Gudelsky, G. A. (2010). Amphetamine toxicities: classical and emerging mechanisms. Ann. N.Y. Acad. Sci. 1187, 101-121. doi: 10.1111/j.1749-6632.2009.05141.x
159. Ye, L., Peng, J. S., Wang, X., Wang, Y. J., Luo, G. X., and Ho, W. Z. (2008). Methamphetamine enhances Hepatitis C virus replication in human hepatocytes. J. Viral Hepat. 15, 261-270. doi: 10.1111/j.1365-2893.2007.00940.x
160. Yu, Q., Larson, D. F., and Watson, R. R. (2003). Heart disease, methamphetamine and AIDS. Life Sci. 73, 129-140. doi: 10.1016/S0024-3205(03)00260-1
161. Yu, Q., Zhang, D., Walston, M., Zhang, J., Liu, Y., and Watson, R. R. (2002). Chronic methamphetamine exposure alters immune function in normal and retrovirus-infected mice. Int. Immunopharmacol. 2, 951-962. doi: 10.1016/S1567-5769(02)00047-4
162. Zou, J. Y., and Crews, F. T. (2005). TNF alpha potentiates glutamate neurotoxicity by inhibiting glutamate uptake in organotypic brain slice cultures: neuroprotection by NF kappa B inhibition. Brain Res. 1034, 11-24. doi: 10.1016/j.brainres.2004.11.014